Using computer models to predict results of total knee replacement in knee osteoarthritis
Tests whether pre-surgery data can predict knee replacement outcomes in people with knee osteoarthritis.
Key facts
- Who runs it
- Fondazione Policlinico Universitario Campus Bio-Medico
- Where
- Rome, ItalySee the site
- Trial code
- Registry title
- An Artificial Intelligence-based Approach in Total Knee Arthroplasty: From Inflammatory Responses to Personalized Medicine
- Status
- Recruiting
- People taking part
- 197 people, planned
- Started
- 14 Oct 2024
- Expected to end
- Dec 2029
- Type of study
- Interventional
- Treatments tested
- Total Knee Arthroplasty
- Multifaceted diagnostic assessments
- Follow-ups
- Genetic screening
- Record updated
- 4 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with end-stage knee osteoarthritis that causes symptoms, who will have a total knee replacement. It studies whether data collected before surgery, with AI, can predict results.
- Age
- Older than 18 years
- Sex
- All sexes
- Disease stage
- Symptomatic, end-stage knee osteoarthritis. The knee ligaments must still work properly.
- Earlier treatment
- People who had a joint fracture or knee surgery before cannot join. Past knee arthroscopy (keyhole surgery) or meniscus surgery is allowed.
Main reasons for not taking part
- Nerve or other conditions that make it hard to take part in walking tests
- Inflammatory or infectious arthritis
- Previous joint fracture or knee surgery, other than knee arthroscopy or meniscus surgery
- Active tumors
- Pregnancy
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Symptomatic, end-stage knee osteoarthritis
- Ligaments functionally intact
- Age: older than18 years old
Who cannot take part
- Previous articular fracture or knee surgery (excluding knee arthroscopy and meniscal surgery)
- Neurological or other conditions affecting patients ability to join walking trials
- Inflammatory or infectious arthritis
- Active tumors or pregnancy
Where in Italy
- Fondazione Policlinico Universitario Campus Bio-MedicoRome, ItalyContact: Umile Giuseppe Longo, MD, MSc, PhD (principal investigator)Taking people
About the trial
What the trial wants to find out
Goal: The goal of this interventional study is to understand how multimodal preoperative data can predict outcomes after Total Knee Arthroplasty (TKA) and improve personalized medicine practices.
Read full original descriptionShow less
Participant Population: The study will enroll 197 patients suffering from symptomatic, end-stage knee osteoarthritis, who are above 18 years old and have functionally intact ligaments.
Main Questions:
* Can multimodal preoperative data, genetic predisposition, and psycho-behavioral characteristics predict outcomes after TKA? * Can AI models effectively use this data to customize prostheses and surgical interventions, and predict patient outcomes? Comparison Group Information (If applicable): Not specified in the provided details.
Participant Tasks:
* Undergo TKA as per the normal clinical routine. * Participate in pre- and post-surgical follow-ups including: * Clinical-functional assessments. * Administration of clinical scores. * Collection of biological samples. * Biomechanical analysis using a stereophotogrammetric system. * Provide data for the comprehensive multimodal indexed database.
The group in the trial
- Patients who undergo total total knee arthroplastyTreatment being tested
The study population comprises 197 patients who require Total Knee Arthroplasty (TKA) due to symptomatic, end-stage knee osteoarthritis. Eligible participants are adults over the age of 18 years with functionally intact ligaments. Exclusion criteria include individuals with neurological or other conditions that affect their ability to participate in walking trials, those with inflammatory or infectious arthritis, previous significant knee surgeries such as articular fractures (excluding knee arthroscopy and meniscal surgery), and those with active tumors or who are pregnant. This population selection is aimed at assessing the efficacy of AI-integrated interventions in improving surgical outcomes and postoperative recovery in a homogeneous group affected by severe knee degeneration.
Treatment: Total Knee Arthroplasty, Multifaceted diagnostic assessments, Follow-ups, and Genetic screening
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- An Artificial Intelligence-based Approach in Total Knee Arthroplasty: From Inflammatory Responses to Personalized Medicine
- Plain-language title
- Using computer models to predict results of total knee replacement in knee osteoarthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Publications
- Joint modeling and marker set selection significantly influence functional biomechanics in end-stage knee osteoarthritis: evidence from the sit-to-stand task.Frontiers in bioengineering and biotechnology, 2025
- Record updated
- 4 March 2026